Aesthetic Technology develops ventilator to support global covid-19 fight

Dermalux manufacturer Aesthetic Technology has become the first independent UK company to launch a ventilator in response to the covid-19 pandemic.

The company has completed the development and launch of a fully compliant ventilator. Due to its regulatory compliance, the Aesthetic Technology C-19 Ventilator will be available for delivery around the world.  

Working virtually 24/7 for the past month, the company completed the project quickly, utilising a mixture of its existing supply chain and new specialist component manufacturers. 

The Aesthetic Technology C-19 Ventilator is based on an existing fully-approved design for which the company has a worldwide permissive licence from Medtronic to manufacture for the duration of the pandemic. The ventilator is compact, lightweight and portable, and provides airway support for both children and adults.

“In these unprecedented times, as a fully-certified manufacturer of medical equipment, we are pleased to be able to play our part and contribute to the covid-19 cause, not just here in the UK but on a worldwide basis too”, said Huw Anthony, chief executive of Aesthetic Technology. 

Managing director Dale Needham added, “As a registered medical device manufacturer we felt that it was our duty to look at the feasibility of creating and manufacturing a fully compliant ventilator. 

“It has been a very busy month, but I am delighted that we have succeeded in our goal as we now enter the manufacturing stage. Our C-19 Ventilator will be manufactured at our Warrington factory on a new production line set up specifically for this project.”

“Whilst we had the advantage of starting with an existing design, we still encountered a number of challenges throughout the process, and there was a lot of work in re-engineering a number of components. I am pleased to say that we have some fantastic technical talent at our disposal, which has proved invaluable to us in achieving our goal.”

In other covid-19 news, Dr Ravi Brar looks at the reliability of dermatological signs in indicating presence of the virus.